Literature DB >> 11483174

Ultraviolet and middle wavelength sensitive cone responses in the electroretinogram (ERG) of normal and Rpe65 -/- mice.

B Ekesten1, P Gouras, D J Salchow.   

Abstract

Ultra-violet (UV) and middle wavelength sensitive (M) cone responses were identified in the ERG of normal and Rpe65 -/- mice using chromatic flashes and selective chromatic adaptation. In normal mice, the UV-cone response was as large as, or larger, in the presence of a bright yellow adapting light than it is in the presence of a dim white light. The M-cone response became undetectable in the presence of the yellow adapting light. Yellow adapting light initially reduced the UV response, but it recovered in 8-10 min. The M-cone response did not recover. UV-cone responses were undetectable in Rpe65 -/- mice. The M-cone response of young Rpe65 -/- mice was almost as large as in normal mice. A yellow adapting light only diminished this M-cone response. With age, the M-cone response further decreased in Rpe -/- mice. We show a pronounced loss of UV-cone function in Rpe65 -/- mice, which may be related to a defect UV-cones share with rods. The M-cone function is also affected already in young Rpe65 -/- mice. The transient effect of a yellow adapting light on the UV-cone response of normal mice is suggested to be neural, because it disappears during maintained light adaptation.

Entities:  

Mesh:

Year:  2001        PMID: 11483174     DOI: 10.1016/s0042-6989(01)00140-7

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  9 in total

Review 1.  RPE65: role in the visual cycle, human retinal disease, and gene therapy.

Authors:  Xue Cai; Shannon M Conley; Muna I Naash
Journal:  Ophthalmic Genet       Date:  2009-06       Impact factor: 1.803

2.  Comparison of ocular pathologies in vitamin A-deficient mice and RPE65 gene knockout mice.

Authors:  Yang Hu; Ying Chen; Gennadiy Moiseyev; Yusuke Takahashi; Robert Mott; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

3.  S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.

Authors:  Adarsha Koirala; Rasha S Makkia; Shannon M Conley; Mark J Cooper; Muna I Naash
Journal:  Hum Mol Genet       Date:  2013-01-18       Impact factor: 6.150

4.  Ex vivo electroretinograms made easy: performing ERGs using 3D printed components.

Authors:  Paul J Bonezzi; Matthew J Tarchick; Jordan M Renna
Journal:  J Physiol       Date:  2020-09-26       Impact factor: 5.182

5.  Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.

Authors:  Alexis-Pierre Bemelmans; Corinne Kostic; Sylvain V Crippa; William W Hauswirth; Janis Lem; Francis L Munier; Mathias W Seeliger; Andreas Wenzel; Yvan Arsenijevic
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

6.  Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo.

Authors:  Ammaji Rajala; Yuhong Wang; Ye Zhu; Michelle Ranjo-Bishop; Jian-Xing Ma; Chuanbin Mao; Raju V S Rajala
Journal:  Nano Lett       Date:  2014-08-12       Impact factor: 11.189

7.  The frequency-response electroretinogram distinguishes cone and abnormal rod function in rd12 mice.

Authors:  Xufeng Dai; Hua Zhang; Ying He; Yan Qi; Bo Chang; Ji-jing Pang
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 8.  Electrophysiological analysis of visual function in mutant mice.

Authors:  Neal S Peachey; Sherry L Ball
Journal:  Doc Ophthalmol       Date:  2003-07       Impact factor: 1.854

9.  Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue.

Authors:  Chooi-May Lai; Meaghan Jt Yu; Meliha Brankov; Nigel L Barnett; Xiaohuai Zhou; T Michael Redmond; Kristina Narfstrom; P Elizabeth Rakoczy
Journal:  Genet Vaccines Ther       Date:  2004-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.